➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Dow
Colorcon
AstraZeneca
Harvard Business School

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Tranxition, Inc. v. Lenovo (United States) Inc. (Fed. Cir. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Tranxition, Inc. v. Lenovo (United States) Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Tranxition, Inc. v. Lenovo (United States) Inc.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Tranxition, Inc. v. Lenovo (United States) Inc. (Fed. Cir. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-12-07 134 3-27:9) (’215 Patent); A1377(49:13-18); A1384(79:3-10); A1385(83:10-18) (’625 Patent)]. Thus…three Ericsson patents—the ’568, ’215, and ’625 Patents—and validity of the ’625 Patent. [A231-33] The…:14) (’215 Patent); A1395(122:3-122:10) (’568 Patent); A1389(97:14-16) (’625 Patent)] And at trial…of Law Patents-in-Suit the ’435, ’625, ’568, ’223, and ’215 Patents FRAND… three of Ericsson’s patents, given that: a) ’568 Patent: Defendants’ products External link to document
2015-11-20 36 U.S.C. § 102(b) as anticipated by Digibox. Pet. 5, 8– 8–32. a. Digibox (Ex. …transitional proceeding only for a patent that is a covered business method patent." AIA § 18(a)(1)(E). …restrictions; not every patent petitioned is a covered business method. Indeed, the two patents for which JPMC…IPR-Related Patents Finally, JPMC urges the Court to find jurisdiction to stay all five patents in this… remaining three patents because no CBMR petitions have been filed for those patents (and none instituted External link to document
2016-02-11 43 1338, 1341. During prosecution of U.S. Patent No. 6,620,847, the patentee made arguments equating “…the other patent in suit, U.S. Patent No. 7,346,766 (“’766 patent”). (JA0244.) The ’766 patent issued on… U.S. Patent No. 6,728,877 (“’877 patent”) eventually issued. (JA0073.) Before the ’877 patent issued…pages. See Internet Patents, 790 F.3d at 1344; U.S. Patent No. 7,707,505. IPC’s patented technology affected…Original, Abandoned Patent Application On April 28, 1999, Tranxition filed U.S. Patent Application No External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
McKinsey
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.